The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase

International Journal of Cancer

Volumn 127, Issue 8, 2010, Pages 1975-1983

  Chang, Da Young ^a   Yoo, Seung Wan ^a   Hong, Youngtae ^b   Kim, Sujeong ^b   Kim, Se Joong ^a   Yoon, Sung Hwa ^a   Cho, Kyung Gi ^a   Paek, Sun Ha ^c   Lee, Young Don ^a   Kim, Sung Soo ^a   Suh Kim, Haeyoung ^a  

^a Ajou University School of Medicine   (South Korea)

^b Viromed Co Ltd   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

5 fluorocytosine; cytosine deaminase; glioma; mesenchymal stem cells; spleen forming focus virus; suicide gene

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GAG PROTEIN; POL PROTEIN;

ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER INHIBITION; CANCER RECURRENCE; CANCER STAGING; CHILD; COCULTURE; DRUG CYTOTOXICITY; ENVELOPE GENE; ENZYME ACTIVITY; EX VIVO STUDY; GENE THERAPY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; STEM CELL TRANSPLANTATION; SUICIDE GENE; TUMOR GROWTH; ANIMAL; BYSTANDER EFFECT; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TUMOR CELL CULTURE;

ADOLESCENT; ANIMALS; BRAIN NEOPLASMS; BYSTANDER EFFECT; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GENE THERAPY; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 77957006357     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25383     Document Type: Article

References (40)

1. Surawicz TS, Davis F, Freels S, Laws ER, Jr., Menck HR,. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 1998; 40: 151-60.
2. Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS,. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999; 91: 1382-90.
3. Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE,. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res 1995; 55: 4808-12.
4. Mullen CA, Kilstrup M, Blaese RM,. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 1992; 89: 33-7.
5. Portsmouth D, Hlavaty J, Renner M,. Suicide genes for cancer therapy. Mol Aspects Med 2007; 28: 4-41.
6. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ,. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004; 101: 18117-22.
7. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF,. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65: 3307-18.
8. Kuratsu J, Yoshizato K, Yoshimura T, Leonard EJ, Takeshima H, Ushio Y,. Quantitative study of monocyte chemoattractant protein?1 (MCP?1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst 1993; 85: 1836-9.
9. Kendall SE, Najbauer J, Johnston HF, Metz MZ, Li S, Bowers M, Garcia E, Kim SU, Barish ME, Aboody KS, Glackin CA,. Neural stem cell targeting of glioma is dependent on phosphoinositide 3?kinase signaling. Stem Cells 2008; 26: 1575-86.
10. Birnbaum T, Roider J, Schankin CJ, Padovan CS, Schichor C, Goldbrunner R, Straube A,. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 2007; 83: 241-7.
11. Schmidt NO, Przylecki W, Yang W, Ziu M, Teng Y, Kim SU, Black PM, Aboody KS, Carroll RS,. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005; 7: 623-9.
12. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY,. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97: 12846-51.
13. Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM, Carroll RS,. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 2006; 12: 5550-6.
14. Kim SU, Lee HJ, Park IH, Chu K, Lee ST, Kim M, Roh JK, Kim SK, Wang KC,. Human Nerual Stem Cells for Brain Repair. Int J Stem Cells 2008; 1: 27-35.
15. Erices A, Conget P, Minguell JJ,. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109: 235-42.
16. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH,. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669-75.
17. Lazennec G, Jorgensen C,. Concise review: adult multipotent stromal cells and cancer: risk or benefit. Stem Cells 2008; 26: 1387-94.
18. Lucas ML, Seidel NE, Porada CD, Quigley JG, Anderson SM, Malech HL, Abkowitz JL, Zanjani ED, Bodine DM,. Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes. Blood 2005; 106: 51-8.
19. Kim SS, Choi JM, Kim JW, Ham DS, Ghil SH, Kim MK, Kim?Kwon Y, Hong SY, Ahn SC, Kim SU, Lee YD, Suh?Kim H,. cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal?regulated kinase/MAPK. Neuroreport 2005; 16: 1357-61.
20. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
21. Kim SS, Choi JW, Kwack KB, Lee YD, Suh?Kim H,. Effects of basic fibroblast growth factor on proliferation of human mesenchymal stem cells. Korean J Anatomy 2004; 37: 509-17.
22. Kim SS, Yoo SW, Park TS, Ahn SC, Jeong HS, Kim JW, Chang DY, Cho KG, Kim SU, Huh Y, Lee JE, Lee SY, et al. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 2008; 26: 2217-28.
23. Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, Oh W, Park SH, Sung YC, Jeun SS,. Gene therapy using TRAIL?secreting human umbilical cord blood?derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008; 68: 9614-23.
24. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y, Hamada H,. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155-64.
25. Malhi H, Gores GJ,. TRAIL resistance results in cancer progression: a TRAIL to perdition. Oncogene 2006; 25: 7333-5.
26. Watters JJ, Schartner JM, Badie B,. Microglia function in brain tumors. J Neurosci Res 2005; 81: 447-55.
27. Jordan JT, Sun W, Hussain SF, DeAngulo G, Prabhu SS, Heimberger AB,. Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. Cancer Immunol Immunother 2008; 57: 123-31.
28. Kaliberov SA, Market JM, Gillespie GY, Krendelchtchikova V, Della Manna D, Sellers JC, Kaliberova LN, Black ME, Buchsbaum DJ,. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma. Gene Ther 2007; 14: 1111-9.
29. Erbs P, Regulier E, Kintz J, Leroy P, Poitevin Y, Exinger F, Jund R, Mehtali M,. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res 2000; 60: 3813-22.
30. Grez M, Akgun E, Hilberg F, Ostertag W,. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci USA 1990; 87: 9202-6.
31. Kaneko S, Onodera M, Fujiki Y, Nagasawa T, Nakauchi H,. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice. Hum Gene Ther 2001; 12: 35-44.
32. Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W,. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 1995; 69: 7541-7.
33. Ohnishi N, Itoh K, Itoh Y, Baum C, Higashitsuji H, Yamaguchi K, Tsuji T, Okanoue T, Fujita J,. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo. Gene Ther 2002; 9: 303-6.
34. Djouad F, Bony C, Apparailly F, Louis-Plence P, Jorgensen C, Noel D,. Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation 2006; 82: 1060-6.
35. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F,. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007; 21: 304-10.
36. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, Zhang J, Raffeld M, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006; 203: 1235-47.
37. Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C,. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007; 67: 6304-13.
38. Kucerova L, Matuskova M, Pastorakova A, Tyciakova S, Jakubikova J, Bohovic R, Altanerova V, Altaner C,. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med 2008; 10: 1071-82.
39. Alvarez RD, Gomez-Navarro J, Wang M, Barnes MN, Strong TV, Arani RB, Arafat W, Hughes JV, Siegal GP, Curiel DT,. Adenoviral-mediated suicide gene therapy for ovarian cancer. Mol Ther 2000; 2: 524-30.
40. Akbulut H, Zhang L, Tang Y, Deisseroth A,. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther 2003; 10: 388-95.